SurgiQuest Revenue and Competitors
Estimated Revenue & Valuation
- SurgiQuest's estimated annual revenue is currently $3.3M per year.
- SurgiQuest's estimated revenue per employee is $251,000
Employee Data
- SurgiQuest has 13 Employees.
- SurgiQuest grew their employee count by -13% last year.
SurgiQuest's People
Name | Title | Email/Phone |
---|---|---|
1 | Sr. Director Sales | Reveal Email/Phone |
SurgiQuest Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $30.6M | 122 | 4% | N/A | N/A |
#2 | $31.6M | 126 | -4% | N/A | N/A |
#3 | $17.8M | 71 | 0% | N/A | N/A |
#4 | $8.5M | 34 | -8% | N/A | N/A |
#5 | $5M | 20 | -31% | N/A | N/A |
#6 | $36.6M | 146 | 8% | N/A | N/A |
#7 | $7.3M | 29 | 4% | N/A | N/A |
#8 | $6.8M | 27 | 0% | N/A | N/A |
#9 | $543.2M | 2164 | 3% | N/A | N/A |
#10 | $0.3M | 1 | -90% | N/A | N/A |
What Is SurgiQuest?
As a company, SurgiQuest is focused on how its technology can improve not only how surgical operations are performed but by how patients respond to surgery itself, both during and after the procedure. We have two major product lines: AirSeal®, the world's only intelligent and integrated access system for laparoscopic and robotic surgery, representing a revolutionary transformation of conventional insufflation, trocar, and filtered tubing systems used for the last 20 years. By providing stable pneumoperitoneum, continuous smoke evacuation, and valve-free access to the abdominal cavity, the AirSeal® System reduces procedural time, costs, and hassles in ways that conventional insufflation, trocar, and filtered tubing systems simply cannot do. AnchorPort® is the world's only self-adjusting, self-anchoring 5mm trocar featuring a bladeless, optical tip for direct, visualized entry and a very small cannula housing resulting in a remarkably small “footprint†on the abdomen and allows for a wide range of instrument movement and manipulation in laparoscopic surgery. The AnchorPort® trocar's elastomeric cannula automatically adjusts to the patient's abdominal wall thickness extending the internal angles of access and the effective range of laparoscopic devices including laparoscopes, hand instruments, and both mechanical and thermal ligation instruments.
keywords:N/AN/A
Total Funding
13
Number of Employees
$3.3M
Revenue (est)
-13%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2M | 13 | 8% | N/A |
#2 | $1.2M | 14 | -39% | N/A |
#3 | $1.3M | 15 | 36% | N/A |
#4 | $1.3M | 15 | 7% | N/A |
#5 | $1.3M | 15 | 0% | N/A |